Squawk Pod: News from Netflix & linking GLP-1s & mental health - 04/17/26 | Audio Only

Watch on YouTube ↗  |  April 17, 2026 at 16:53  |  30:30  |  CNBC
Speakers
Joe Kernen — Co-Anchor, Squawk Box

Summary

This episode of Squawk Pod covers geopolitical developments in the Middle East, including a ceasefire between Israel and Lebanon and negotiations with Iran, with analysis from retired General Mark Kimtt. Business news includes Netflix's earnings miss and CEO departure, along with potential government adoption of Anthropic's AI model. The discussion also features obesity expert Dr. Angela Fitch on the link between GLP-1 weight loss drugs and mental health, highlighting market implications.

  • Israel and Lebanon agree to a 10-day ceasefire amid ongoing regional tensions.
  • President Trump expresses optimism on Iran deal, but reports suggest a 20-year suspension of nuclear activities may be discussed.
  • Netflix shares fall after missing profit estimates and announcing co-founder Reed Hastings will step down from the board.
  • Anthropic may provide its Mythos AI model to US government agencies despite previous tensions with the Pentagon.
  • Retired General Mark Kimtt analyzes Iran negotiations and implications for US defense industry and Middle East allies.
  • Obesity expert Dr. Angela Fitch discusses GLP-1 drugs' effects on mood, citing clinical data that shows overall improvement and large market potential.
  • Market commentary includes NASDAQ's 12-day winning streak and oil price movements around $90 per barrel.
  • Hosts Joe Kernen and Kelly Evans provide insights on Netflix's challenges, including content perception and price hikes.
Trade Ideas
Joe Kernen Co-Anchor, Squawk Box 5:57
Netflix faces growth and content challenges.
Netflix faces growth challenges due to content being perceived as 'woke', price hikes, and management departure, leading to stock decline and unattractive investment prospects.
Mark Kimmitt Retired Brigadier General, US Army 16:56
US defense may lose Middle East business.
If the US reduces its military presence in the Middle East as part of a deal with Iran, allied nations may purchase defense equipment from Russian or Chinese companies instead of US firms, negatively impacting the US defense industry.
GLP-1 drug market large despite mood concerns.
The market for GLP-1 drugs remains large despite anecdotal concerns about mood side effects, as clinical data shows most patients' mood improves with obesity treatment, and issues like suicidality are not increased, supporting continued growth and adoption.
Up Next

This CNBC video, published April 17, 2026, features Joe Kernen, Mark Kimmitt, Dr. Angela Fitch discussing NFLX, ITA, XBI. 3 trade ideas extracted by AI with direction and confidence scoring.

Speakers: Joe Kernen, Mark Kimmitt, Dr. Angela Fitch  · Tickers: NFLX, ITA, XBI